Wall Street regulators filed civil fraud charges against a company and four people allegedly caught up in a scheme to bilk investors out of nearly a million dollars through a company purported to be a Massachusetts medical cannabis venture.
The Securities and Exchange Commission charged that the head of the operation raised $550,000 from investors …
Ohio lawmakers pass a medical marijuana bill in a bid to undercut a ballot measure, MassRoots’ Nasdaq listing is nixed again, and Congress moves to give military veterans easier access to medical cannabis.
Here’s a closer look at several notable developments in the marijuana industry over the past week.
Denver-based MassRoots, the popular social network for cannabis enthusiasts, failed again to secure a public listing on the Nasdaq, a setback for marijuana companies hoping to trade on a major U.S. stock market.
MassRoots said in a press release the Nasdaq linked its decision to the argument that the company, as a pro-marijuana business, could be …
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and other incentives so it can test the drug on patients with a rare form of the disorder.
The U.S. Food and Drug Administration’s decision gives British-based GW the green light to test its Epidiolex medicine …
MassRoots, the popular social network for cannabis enthusiasts, is taking another shot at getting listed on the Nasdaq.
The Colorado-based company filed an S-1 registration form on Monday with the Securities and Exchange Commission to raise up to $6.5 million by selling shares and warrants – a key part of the process for getting listed on the …
The cannabis industry is attracting investors from all walks of life. Including porn.
Larry Flynt, the famed publisher of Hustler Magazine, has thrown down $100,000 for 100,000 shares of stock in Pineapple Express, a publicly traded company in Los Angeles that provides consulting, property rentals and technology investments to marijuana businesses.
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine it created has successfully treated a severe form of epilepsy in children, according to Reuters.
In a clinical study, GW Pharmaceuticals said its Epidiolex syrup reduced the monthly number of seizures in children with Dravet’s …
Following a brutal 2015 for marijuana stocks, the cannabis investment sector has something to smile about to start the new year. The stock markets will soon welcome a U.S. dispensary to the ranks of the publicly traded: Black Oak Gallery, better known as Blüm Oakland.
Medicine Man Technologies, a Colorado-based cannabis consulting firm tied to the family behind two high-profile marijuana stores, received clearance from the Financial Industry Regulatory Authority on Tuesday to become a publicly traded company.
Its shares will trade on the over-the-counter markets, possibly as soon as mid-January, according to company founder and chief operating officer Brett Roper.